Normangee StarThe Analysts Set $27.00 Price Target for Crispr Therapeutics AG (CRSP)Normangee StarChardan Capital initiated coverage on shares of Crispr Therapeutics AG in a research report on Monday. After $-0.31 actual EPS reported by Intellia Therap… Continue reading
Engadget |
Man receives someone else’s reprogrammed stem cells
Engadget The concept of using stem cells for transplants just became a truly practical reality: a Japanese man with age-related macular degeneration has received the first transplant of stem cells from another human donor. Doctors repurposed the donor’s skin … |
West Fargo Pioneer |
A ‘second chance’: Wheaton woman in trial testing immunotherapy to treat advanced lung cancer
West Fargo Pioneer Dr. Preston Steen meets with Janette Schmidt, 65, Wheaton, Minn., on Wednesday, March 29, 2017, at Roger Maris Cancer Center in Fargo. Schmidt is participating in an immunotherapy research trial to treat her advanced lung cancer. Michael Vosburg … |
The Scientist |
Neoantigens Enable Personalized Cancer Immunotherapy
The Scientist One type of immunotherapy in which a tumor’s neoantigens are suspected to play a role is immune checkpoint inhibitors, which block inhibitory signals that would otherwise repress the body’s cancer-fighting T cells. In both preclinical models and human … |
WLS-TV |
Immunotherapy a potential option for fighting brain tumors
WLS-TV As many as 78,000 Americans will be diagnosed with a brain tumor this year. If those tumors return after surgery, immunotherapy may be an option. It’s a treatment that revs up the body’s immune response to fight the cancer. It’s in its early stages … |
|
Tau Immunotherapy for Aβ?
Alzforum Could antibodies against tau also reduce Aβ pathology? So suggest scientists led by Khalid Iqbal, New York State Institute for Basic Research in Developmental Disabilities, Staten Island. They report that injecting mice with anti-tau antibodies reduced … |